Delivery Order V797P5025B-VA25714J0853
Award Date 1/27/14
Potential Completion Date 3/10/14
Potential Value $22K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Dallas, TX 75216, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Advanced Accelerator Applications USA Inc., a Novartis subsidiary specializing in radiopharmaceutical manufacturing, received a $166,145.70 firm fixed price Blanket Purchase Agreement (BPA) call for PLUVICTO (lutetium Lu 177 vipivotide tetraxetan) on March 28, 2025. This extension contract, which completes July 31, 2025, was awarded by Veterans Integrated Service Network 15 without a small business set-aside designation and will be performed in Millburn, New Jersey. PLUVICTO is an advanced...
- Advanced Accelerator Applications USA Inc., a Novartis subsidiary specializing in radiopharmaceutical manufacturing, was awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call valued at $204,654.54 for the supply of PLUVICTO (lutetium Lu 177 vipivotide tetraxetan) to the Department of Veterans Affairs' Veterans Integrated Service Network 2. The contract, awarded on October 1, 2024, carries an ultimate completion date of September 30, 2025, and will be performed in Millburn, New Jersey....
- This federal contract award to Advanced Accelerator Applications USA Inc., a subsidiary of Novartis, is for the delivery of the radiopharmaceutical product PLUVICTO. The contract has a ceiling value of $97,386.93 and is a Blanket Purchase Agreement (BPA) call order placed under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract is being awarded by the Department of Veterans Affairs (VA) through its Veterans Integrated Service Network 10 (VISN 10). As a...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded a $97,386.93 firm fixed price delivery order to Advanced Accelerator Applications USA Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule. The order is for LU177 PLUVICTO - IC to be delivered to a location in Millburn, New Jersey by June 14, 2024. No set-aside designation was used for this award. Advanced Accelerator Applications USA Inc. will provide the...
- This delivery order, awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21, is valued at approximately $194,773.86 to Advanced Accelerator Applications USA Inc. for the product PLUVICTO URGENT PATIENT(LUTETIUM LU 177 VIPIVOTIDE TETRA 27MCI/ML). The firm fixed price order was issued against the company's Pharmaceuticals and Drugs schedule (FSS-61-IB) and has a completion date of May 26, 2023. No set-aside designation was used for...
- Advanced Accelerator Applications USA Inc., a Novartis subsidiary specializing in radiopharmaceutical manufacturing, received a $896,106.33 firm fixed-price Blanket Purchase Agreement (BPA) call award from the Department of Veterans Affairs' Veterans Integrated Service Network 10 on October 1, 2024. The contract, which is not set-aside for small businesses, covers the supply of PLUVICTO (lutetium Lu 177 vipivotide tetraxetan), an advanced nuclear medicine product used for targeted radioligand...
- This federal contract award is for LUTHATHERA LU 177 MEDICAL SUPPLIES and was awarded to the prime contractor, Advanced Accelerator Applications USA Inc. The contract has a ceiling value of $150,377.88 and was awarded on March 26, 2020, with an ultimate completion date of December 31, 2020. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type. The awarding agency is the Defense Health Agency (DHA), a component of the Department of Defense. Advanced...
- Advanced Accelerator Applications USA Inc., a Novartis subsidiary specializing in radiopharmaceutical manufacturing, was awarded a $1.14M firm fixed-price blanket purchase agreement (BPA) call by the Department of Veterans Affairs' Veterans Integrated Service Network 15 on February 17, 2024. The contract covers the supply of PLUVICTO (lutetium Lu 177 vipivotide tetraxetan) and LUTATHERA (lutetium Lu 177 dotatate), advanced nuclear medicine products used for targeted radioligand therapy and...
- This federal contract award to Advanced Accelerator Applications USA Inc., a subsidiary of Novartis, is for the delivery of six branded nuclear medicine products approved by the FDA, including LUTATHERA and PLUVICTO. The $498,438.38 firm-fixed-price purchase order has a completion date of December 4, 2025 and was awarded on December 4, 2024 by the Defense Health Agency (DHA), a defense agency. The contract is not set aside for small businesses. Advanced Accelerator Applications USA Inc. is a...
- Advanced Accelerator Applications USA Inc. was awarded a $78,520.70 firm fixed price delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. The contract calls for the delivery of lutetium dotatate doses to the agency, with performance taking place in Millburn, New Jersey. No set-aside provisions were applied to this award to supply radiopharmaceutical products in...